dobutamine has been researched along with apelin-13 peptide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bostwick, JS; Brigance, R; Finlay, HJ; Gargalovic, PS; Generaux, CN; Luk, CE; Meng, W; Onorato, JM; Pi, Z; Rossi, KA; Schumacher, WA; Wang, T; Wexler, RR | 1 |
| Auger-Messier, M; Chagnon, F; Coquerel, D; Dumaine, R; Lesur, O; Marsault, E; Salvail, D; Sarret, P | 1 |
2 other study(ies) available for dobutamine and apelin-13 peptide
| Article | Year |
|---|---|
Identification of a Hydroxypyrimidinone Compound (
Topics: Animals; Apelin Receptors; Dogs; Drug Discovery; Heart Failure; Humans; Pyrimidinones; Rats; Structure-Activity Relationship | 2021 |
Apelin Compared With Dobutamine Exerts Cardioprotection and Extends Survival in a Rat Model of Endotoxin-Induced Myocardial Dysfunction.
Topics: Animals; Body Weight; Cardiac Output; Cardiomyopathies; Cardiotonic Agents; Cytokines; Disease Models, Animal; Dobutamine; Intercellular Signaling Peptides and Proteins; Lipopolysaccharides; Male; Mitogen-Activated Protein Kinases; Myocardium; Nitric Oxide Synthase Type II; Peroxidase; Phosphorylation; Plasma Volume; Rats; Survival Rate; Vascular Resistance; Water-Electrolyte Balance | 2017 |